Treatment of a Single Patient With CRD-TMH-001

Clinical trial NCT05514249 · UNKNOWN

Trial details

NCT number: NCT05514249
Sponsor: Cure Rare Disease, Inc
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2022-08-31
Primary completion: 2023-09-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.